Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
60
Number of overlapping holdings
98.4%
% of BBP's 65 holdings also in IBBQ
27.3%
% of IBBQ's 220 holdings also in BBP
Overlap by Weight
Sector Drift (BBP minus IBBQ)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BBP |
Weight in IBBQ |
Overlap | |
|---|---|---|---|---|
 |
GILEAD SCIENCES INC | 2.1% | 8.1% | 2.1% |
|
AMGEN INC | 2.0% | 8.2% | 2.0% |
|
VERTEX PHARMACEUTICALS INC | 1.7% | 8.5% | 1.7% |
|
ALNYLAM PHARMACEUTICALS INC | 1.6% | 3.6% | 1.6% |
|
BIOGEN IDEC INC | 1.6% | 2.1% | 1.6% |
Position Highlights (Non-Overlapping Exposures)
BBP Overweight Relative to IBBQ
|
SAGE THERAPEUTICS INC | 2.1% |
|
TG THERAPEUTICS INC | 2.1% |
 |
ZAI LAB LTD. UNSPONSORED ADR | 2.0% |
|
SPRINGWORKS THERAPEUTICS, INC. | 1.7% |
|
DYNAVAX TECHNOLOGIES CORP | 1.6% |
|
HARMONY BIOSCIENCES HOLDINGS, INC. | 1.5% |
 |
THERAVANCE BIOPHARMA INC | 1.5% |
|
ARDELYX INC | 1.5% |
|
AXSOME THERAPEUTICS, INC. | 1.5% |
|
BIOCRYST PHARMACEUTICALS INC | 1.5% |
BBP Underweight Relative to IBBQ
|
VERTEX PHARMACEUTICALS INC | -6.8% |
|
AMGEN INC | -6.3% |
|
GILEAD SCIENCES INC | -6.0% |
|
REGENERON PHARMACEUTICALS | -5.5% |
 |
ASTRAZENECA PLC-SPONS ADR | -4.4% |
|
ALNYLAM PHARMACEUTICALS INC | -1.9% |
 |
ARGENX SE ADR | -1.9% |
 |
SANOFI-AVENTIS-ADR | -1.7% |
|
SUMMIT THERAPEUTICS INC | -1.5% |
|
ROYALTY PHARMA PLC CLASS A | -1.4% |